IPO registrations (S-1, F-1) · Registrants
Envoy Medical, Inc.
- SEC CIK
- 1840877 · filings on EDGAR ↗
- Former names
- Anzu Special Acquisition Corp I (2021–2023)
- Registration
- Form S-1, first filed 2021-02-08, last 2026-02-10; 4 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2021-03-03; declared effective 2021-03-01
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 3842
- Business address
- 4875 WHITE BEAR PARKWAY, White Bear Lake, MN 55110
- EIN
- 86-1369123
- Ticker
- COCH, COCHW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Envoy Medical, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2021-03-03, an initial public offering)
- Shares sold
- 42,000,000
- Gross proceeds
- $420,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ANZUU
- Lead underwriters
- BofA Securities (25,200,000 shares); Barclays (16,800,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Envoy Medical Corporation Fuzzy (name and state)
- Business registration: ENVOY MEDICAL CORPORATION Fuzzy (name and state)
- Business registration: Envoy Medical, Inc. Fuzzy (name and state)
- Business registration: ENVOY MEDICAL, INC. Fuzzy (name and state)
- Federal award recipient: ENVOY MEDICAL CORPORATION Fuzzy (name and state)
- Lobbying client: ENVOY MEDICAL CORPORATION Fuzzy (name and state)
- Lobbying client: ENVOY MEDICAL CORPORATION Fuzzy (name and state)
- SEC filer: Anzu Special Acquisition Corp I EXACT (CIK (EXACT))
- Person page: William A Wulfsohn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 24
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-08 | S-1 | S-1 (registration) | Anzu Special Acquisition Corp I | 0001104659-21-014526 ↗ |
| 2021-02-19 | S-1/A | S-1/A (amendment) | Anzu Special Acquisition Corp I | 0001104659-21-025855 ↗ |
| 2021-03-01 | S-1MEF | S-1MEF (added securities) | Anzu Special Acquisition Corp I | 0001104659-21-030238 ↗ |
| 2021-03-01 | EFFECT | EFFECT (declared effective) | Anzu Special Acquisition Corp I | 9999999995-21-000779 ↗ |
| 2021-03-03 | 424B4 | 424B4 (final prospectus) | Anzu Special Acquisition Corp I | 0001104659-21-031572 ↗ |
| 2023-09-14 | EFFECT | EFFECT (declared effective) | Anzu Special Acquisition Corp I | 9999999995-23-002658 ↗ |
| 2024-01-18 | S-1 | S-1 (registration) | Envoy Medical, Inc. | 0001213900-24-004577 ↗ |
| 2024-02-15 | S-1/A | S-1/A (amendment) | Envoy Medical, Inc. | 0001213900-24-014271 ↗ |
| 2024-04-05 | S-1/A | S-1/A (amendment) | Envoy Medical, Inc. | 0001213900-24-030821 ↗ |
| 2024-04-25 | S-1/A | S-1/A (amendment) | Envoy Medical, Inc. | 0001213900-24-036229 ↗ |
| 2024-05-02 | EFFECT | EFFECT (declared effective) | Envoy Medical, Inc. | 9999999995-24-001348 ↗ |
| 2024-10-21 | EFFECT | EFFECT (declared effective) | Envoy Medical, Inc. | 9999999995-24-003224 ↗ |
| 2025-08-11 | EFFECT | EFFECT (declared effective) | Envoy Medical, Inc. | 9999999995-25-002550 ↗ |
| 2025-10-17 | S-1 | S-1 (registration) | Envoy Medical, Inc. | 0001213900-25-099775 ↗ |
| 2025-12-01 | S-1/A | S-1/A (amendment) | Envoy Medical, Inc. | 0001213900-25-116721 ↗ |
| 2025-12-18 | S-1 | S-1 (registration) | Envoy Medical, Inc. | 0001213900-25-123367 ↗ |
| 2025-12-30 | EFFECT | EFFECT (declared effective) | Envoy Medical, Inc. | 9999999995-25-003951 ↗ |
| 2026-02-06 | S-1/A | S-1/A (amendment) | Envoy Medical, Inc. | 0001213900-26-013098 ↗ |
| 2026-02-10 | S-1/A | S-1/A (amendment) | Envoy Medical, Inc. | 0001213900-26-013894 ↗ |
| 2026-02-11 | S-1MEF | S-1MEF (added securities) | Envoy Medical, Inc. | 0001213900-26-014612 ↗ |
| 2026-02-11 | EFFECT | EFFECT (declared effective) | Envoy Medical, Inc. | 9999999995-26-000528 ↗ |
| 2026-02-12 | 424B4 | 424B4 (final prospectus) | Envoy Medical, Inc. | 0001213900-26-015230 ↗ |
| 2026-02-12 | 424B4 | 424B4 (final prospectus) | Envoy Medical, Inc. | 0001213900-26-015232 ↗ |
| 2026-06-16 | EFFECT | EFFECT (declared effective) | Envoy Medical, Inc. | 9999999995-26-002008 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-02-19 | S-1/A | registration statement | $10.00 | 35,000,000 | $350,000,000 | Nasdaq ANZU.U | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ | |
| 2021-03-03 | 424B4 | final prospectus | $10.00 | 42,000,000 | $420,000,000 | Nasdaq ANZUU | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Anzu SPAC GP I LLC | TenPercentOwner | Chief Executive Officer | 5 | 2021–2024 | |
| Ganz Peter | Officer | GC and Corporate Secretary | 1 | 2021 | |
| Haring-Smith Whitney | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | Chief Executive Officer | 5 | 2021–2024 | |
| Harris Teresa A | Director | 1 | 2021 | ||
| Huskins Priya Cherian | Director | 2 | 2021–2023 | ||
| Joy John W. | Officer | Chief Financial Officer | 1 | 2021 | |
| Kantor Susan | Director | 7 | 2021–2026 | ||
| WULFSOHN WILLIAM A | Director | 1 | 2021 | person page Fuzzy | |
| DEWBREY DIANE L | Director | 3 | 2022–2023 | ||
| Hirsch Daniel J. | Director,Officer | CFO and Corporate Secretary | 3 | 2022–2023 | |
| Atlas Merchant Capital LLC | TenPercentOwner | 1 | 2023 | ||
| BARCLAYS PLC | TenPercentOwner | 2 | 2023 | ||
| BRYNELSEN CHARLES | Director | 5 | 2023–2026 | ||
| Lucas Brent T. | Director,Officer | Chief Executive Officer | 11 | 2023–2026 | |
| Patel Mona Chetan | Director | 8 | 2023–2026 | ||
| Smith-Gomez Janis | Director | 3 | 2023–2025 | ||
| TAYLOR GLEN A | Director,TenPercentOwner; TenPercentOwner | 13 | 2023–2026 | ||
| Wells David R. | Officer | Chief Financial Officer | 2 | 2023 | |
| Crowe Michael Curtis | Director | 3 | 2024–2025 | ||
| Potashnick Robert | Officer | CAO & VP of Finance; Interim CFO | 4 | 2025–2026 | |
| McKhann Chas | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Envoy Medical Corporation | MN | State business registries | name and state |
| Business registration | ENVOY MEDICAL CORPORATION | MN | State business registries | name and state |
| Business registration | Envoy Medical, Inc. | MN | State business registries | name and state |
| Business registration | ENVOY MEDICAL, INC. | MN | State business registries | name and state |
| Plan sponsor | ENVOY MEDICAL CORPORATION | MN | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | ENVOY MEDICAL CORPORATION | MN | Federal spending (USAspending) | name and state |
| Lobbying client | ENVOY MEDICAL CORPORATION | MN | Federal lobbying (LDA) | name and state |
| Lobbying client | ENVOY MEDICAL CORPORATION | MN | Federal lobbying (LDA) | name and state |
| Patent assignee | Envoy Medical Corporation | MN | Patents (USPTO) | name and state |
| SEC filer | Envoy Medical, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Envoy Medical Corporation | MN | Trademarks (USPTO) | name and state |
| Person page | William A Wulfsohn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Orthopedic, Prosthetic & Surgical Appliances & Supplies, MN first:
- AMERICAN MEDICAL SYSTEMS HOLDINGS INC MN
- Restore Medical, Inc. MN
- Anteris Technologies Global Corp. MN
- BioHorizons, Inc. AL
- LAKELAND INDUSTRIES INC AL
- ALIGN TECHNOLOGY INC AZ
- CARDIMA INC CA
- INTUITIVE SURGICAL INC CA
- DJ ORTHOPEDICS CAPITAL CORP CA
- DJO, LLC CA
In other datasets, the same topic (Technology) in MN:
- Form D issuer: 313 Software, LLC (Form D private offerings)
- Lobbying client: ACA INTERNATIONAL (Federal lobbying (LDA))
Interests: Orthopedic, Prosthetic & Surgical Appliances & Supplies · Technology